HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications
European Respiratory Journal · 2026-03 · 67 (3) · 2502012
DOI: 10.1183/13993003.02012-2025 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 05.03.2026. Verfasst von Qing Long und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, China. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
- Department of Dermatology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China 619319374@qq.com.
ORCID-Profile: Qing Long
Zitieren
APA
Long, Q., & Li, Y. (2026). HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications. European Respiratory Journal, 67(3), 2502012. https://doi.org/10.1183/13993003.02012-2025
Vancouver
Long Q, Li Y. HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications. European Respiratory Journal. 2026;67(3):2502012. doi:10.1183/13993003.02012-2025
BibTeX
@article{Long2026,
author = {Long, Qing and Li, Yan},
title = {HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications},
journal = {European Respiratory Journal},
year = {2026},
volume = {67},
number = {3},
pages = {2502012},
doi = {10.1183/13993003.02012-2025}
}
EUVIMED